Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
- Status
- UNKNOWN
- Phase
- N/A
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Cellular Therapy With Cord Blood Cells
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Membranous Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Rituxan in Churg Strauss Syndrome With Renal Involvement
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)
- Status
- COMPLETED
- Phase
- PHASE2
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- NA
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
VELCADE,Rituximab,Cyclophosphamide and Decadron
- Status
- TERMINATED
- Phase
- PHASE2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g
- Status
- WITHDRAWN
- Phase
- PHASE3